Triple-negative breast cancer (TNBC), which has been reported to represent approximately 15% of all breast cancers1, is characterized by the absence of estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor-2 (HER-2) expression2. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.